Guo Yao Liu
Direktor/Vorstandsmitglied bei Automatic Result Ltd.
Profil
Guo Yao Liu is currently a Director at Automatic Result Ltd.
and a Director at Shenzhen Watsin Genetech Ltd.
Previously, he was the Chief Executive Officer & Executive Director at Uni-Bio Science Group Ltd.
from 2011 to 2014.
Aktive Positionen von Guo Yao Liu
| Unternehmen | Position | Beginn |
|---|---|---|
Automatic Result Ltd.
 Automatic Result Ltd. Financial ConglomeratesFinance Part of MJKPC Holdings Ltd., Automatic Result Ltd. is an investment holding There is no available country named vg company. | Direktor/Vorstandsmitglied | - |
Shenzhen Watsin Genetech Ltd.
 Shenzhen Watsin Genetech Ltd. BiotechnologyHealth Technology Shenzhen Watsin Genetech Ltd. engages in the research, development, manufacture, and sale of biopharmaceutical products and genetic engineering drugs. Its products include genetic engineering products, peptides, recombinant human epidermal growth factor liquid preparation, computer software. The company was founded on April 22, 1997 and is headquartered in Shenzhen, China. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Guo Yao Liu
| Unternehmen | Position | Ende |
|---|---|---|
| UNI-BIO SCIENCE GROUP LIMITED | Vorstandsvorsitzender | 28.02.2014 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| UNI-BIO SCIENCE GROUP LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Automatic Result Ltd.
Automatic Result Ltd. Financial ConglomeratesFinance Part of MJKPC Holdings Ltd., Automatic Result Ltd. is an investment holding There is no available country named vg company. | Finance |
Shenzhen Watsin Genetech Ltd.
Shenzhen Watsin Genetech Ltd. BiotechnologyHealth Technology Shenzhen Watsin Genetech Ltd. engages in the research, development, manufacture, and sale of biopharmaceutical products and genetic engineering drugs. Its products include genetic engineering products, peptides, recombinant human epidermal growth factor liquid preparation, computer software. The company was founded on April 22, 1997 and is headquartered in Shenzhen, China. | Health Technology |
